1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
Ray McDermott, Cornelis M. van Tilburg, Anna F. Farago, Shivaani Kummar, Daniel Shao-Weng Tan, Catherine M. Albert, Jordan Berlin, Ulrik Lassen, François Doz, Birgit Geoerger, Leo Mascarenhas, Noah Federman, John A. Reeves, L. Dima, Nicoletta Brega, Esther De La Cuesta, Theodore W. Laetsch, David S. Hong, Alexander Drilon
Topics & Concepts
Trk receptorMedicineInternal medicineClinical endpointCancerOncologyClinical trialSurgeryReceptorNeurotrophinLung Cancer Treatments and MutationsGlioma Diagnosis and TreatmentChromatin Remodeling and Cancer